Lessons from the ‘Iressa’ Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations

Some subgroups of patients with advanced/metastatic non-small-cell lung cancer (NSCLC) are frequently considered ineligible for the aggressive, platinum-based combination chemotherapy that is the recommended treatment. Elderly patients may have a poorer tolerance of chemotherapy due to impaired orga...

Descripción completa

Detalles Bibliográficos
Autores principales: Stahel, R, Rossi, A, Petruzelka, L, Kosimidis, P, de Braud, F, Bernardo, M M, Souquet, P-J, Parra, H Soto, Gridelli, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750243/
https://www.ncbi.nlm.nih.gov/pubmed/14661049
http://dx.doi.org/10.1038/sj.bjc.6601479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750243/
https://www.ncbi.nlm.nih.gov/pubmed/14661049
http://dx.doi.org/10.1038/sj.bjc.6601479

Ejemplares similares